COMBINATION TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA

The invention relates to the treatment of chronic lymphocytic leukemia, in particular to the treatment of chronic lymphocytic leukemia with a combination treatment comprising a bispecific antibody that binds CD1d and a Vγ9Vδ2-T cell receptor and an agonistic CD1d ligand.

Saved in:
Bibliographic Details
Main Authors KATER, Arnon Philip, RUBEN, Jurjen Matthijs, DE GRUIJL, Tanja Denise, VAN DER VLIET, Johannes Jelle, PARREN, Paul Willem Henri Ida, LAMERIS, Roeland
Format Patent
LanguageEnglish
French
German
Published 06.12.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the treatment of chronic lymphocytic leukemia, in particular to the treatment of chronic lymphocytic leukemia with a combination treatment comprising a bispecific antibody that binds CD1d and a Vγ9Vδ2-T cell receptor and an agonistic CD1d ligand.
Bibliography:Application Number: EP20220176203